Effect of Self-directed and Supervised Pulmonary Rehabilitation Approach on Cough and Sputum.

September 12, 2022 updated by: Usman Farooq, Afridi Medical Complex

Effect of Self-directed and Supervised Pulmonary Rehabilitation Approach on Cough and Sputum Expectoration in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD)is a multifactorial, progressive chronic lung disease that causes airflow restriction. Study was conducted To Compare the effects of supervised and self-directed pulmonary rehabilitation on cough and sputum expectoration in patients of chronic obstructive pulmonary disease.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To Compare the effects of supervised and self-directed pulmonary rehabilitation on cough and sputum expectoration in patients of chronic obstructive pulmonary disease. It was a randomised control trial and participants were COPD Patients.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • KP
      • Peshawar, KP, Pakistan
        • Pulmonary Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

36 years to 56 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 40 to 60
  • Gender: Both Males & Females.
  • Diagnoses with an exacerbation of COPD.
  • Informed consent obtained.

Exclusion Criteria:

  • Inability to provide informed consent or complete a self-administered questionnaire.
  • Patients with trauma.
  • Females who were pregnant and breastfeeding.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
home based plan of aerobic exercises, strengthening exercises of upper and lower limbs and huffing and coughing
Pulmonary Rehabilitation Techniques
Placebo Comparator: Group B
Supervised aerobic exercises, strengthening exercises of upper and lower limbs and huffing and coughing
Pulmonary Rehabilitation Techniques

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six minute walk test
Time Frame: 6 months
to measure distance walked in six minutes
6 months
Cough & sputum assessment questionnaire.
Time Frame: 6 months
recall assesses the frequency and severity of cough and sputum and their impact on everyday life
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
leicester cough questionnaire
Time Frame: 6 months
This questionnaire is designed to assess the impact of cough on various aspects of your life.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Syed Alamdar Hussain, Phd, Afridi Medical Complex

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2022

Primary Completion (Actual)

July 28, 2022

Study Completion (Actual)

August 21, 2022

Study Registration Dates

First Submitted

September 8, 2022

First Submitted That Met QC Criteria

September 12, 2022

First Posted (Actual)

September 14, 2022

Study Record Updates

Last Update Posted (Actual)

September 14, 2022

Last Update Submitted That Met QC Criteria

September 12, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0112

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Disease

Clinical Trials on Physiotherapy Treatment

Subscribe